mTOR inhibition overcomes docetaxel chemoresistance in prostate cancer cell and mouse models through downregulation of sphingosine kinase 1
Hassan Alshaker(University of East Anglia), Dmitri Pchejetski(University of East Anglia), Q. Wang, Mathias Winkler(National Health Service), Colin Cooper(Institute of Cancer Research)
Cited by 0
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
|Cancer Research|2005|203
Oxidative Stress–Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A–Associated Cardiac Cell Apoptosis
|Circulation Research|2006|197
The emerging role of FTY720 (Fingolimod) in cancer treatment
|Oncotarget|2016|174